ARTICLE;
DRUG COMBINATION;
DRUG INTERACTION;
HUMAN;
LITERATURE;
RHEUMATOID ARTHRITIS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
ASPIRIN;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
HUMANS;
METHOTREXATE;
REVIEW LITERATURE AS TOPIC;
Methotrexat og udvikling af interstitiel lungesygdom. Institut for Rationel Farmakoterapi og Center for Klinisk Farmakologi i Odense. (29. jul 2012).
Methotrexat og udvikling af interstitiel lungesygdom. Institut for Rationel Farmakoterapi og Center for Klinisk Farmakologi i Odense. http://irf.dk/dk/ laegemiddelspoergsmaal/methotrexat_og_udvikling_af_interstitiel_lungesygdom. htm (29. jul 2012).
2
82955162596
Paracetamol and cyclooxygenase inhibition: is there a cause for concern?
Hinz B, Brune K. Paracetamol and cyclooxygenase inhibition: is there a cause for concern? Ann Rheum Dis 2012;71:20-5.
Andersen LS. NSAID (Non-steroide antiinflammatoriske midler). M01A. Dansk Lægemiddel Information A/S.
Andersen LS. NSAID (Non-steroide antiinflammatoriske midler). M01A. Dansk Lægemiddel Information A/S. http://pro.medicin.dk/Laegemiddelgrupper/ Grupper/213010.
5
84860802208
Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)
CD008872
Colebatch AN, Marks JL, Edwards CJ. Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). Cochrane Database Syst Rev 2011;(11): CD008872.
Den Nationale Rekommandationsliste. M01 og M09: NSAID, glukosamin og hyaluronsyre. Institut for Rationel Farmakoterapi. (29. jul 2012).
Den Nationale Rekommandationsliste. M01 og M09: NSAID, glukosamin og hyaluronsyre. Institut for Rationel Farmakoterapi. http://irf.dk/dk/rekommandationsliste/ baggrundsnotater/nervesystemet_analgetika_og_psykofarmaka/ m01_og_m09_nsaid_glukosamin_og_hyaluronsyre.htm (29. jul 2012).
7
79958120454
Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study
Olsen AMS, Fosbøl EL, Lindhardsen J et al. Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study. Circulation 2011;123:2226-35.
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors
del Rincón ID, Williams K, Stern MP et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45.
Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial
Bakker MF, Jacobs JW, Welsing PM et al. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial. Ann Intern Med 2012;156:329-39.
Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e initiative
Whittle SL, Colebatch AN, Buchbinder R et al. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e initiative. Rheumatology (Oxford) 2012;51:1416-25.
